Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 218

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 6
Chunk 218
---
 2023, requiring the recovery in full or in part of the components of the Chief Executive Officer's compensation that are wholly or partially contingent on the attainment of financial performance criteria based on financial information that has been determined to be erroneous and has required restatement of the financial statements for accounting purposes.

2024 Compensation of Hervé Brailly

The following table sets forth the compensation earned by Hervé Brailly during the year ended on December 31, 2024:

  Type of Compensation              Amount of Compensation      Description                                                                                                                                   
  Fixed Compensation                €391,667                    Gross fixed compensation pursuant to Hervé Brailly's social mandate ( mandat social).                                                         
  Annual Variable                   €274,950                    This amount represents Hervé Brailly’s annual variable compensation, based on his achievement of 100% of the annual objectives.               
  Compensation— Cash                                                                                                                                                                                          
  Performance Free Shares 2024      €301,500                    This amount was calculated in accordance with the IFRS 2 valuation of the grant to Hervé Brailly's of 150,000 performance free shares 2024.   
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Benefits in Kind                  €6,928                      Primarily represents amounts paid for use of a company car and additional retirement benefits (known as “article 83”), among other benefits.  
  Total Compensation                €975,045                                                                                                                                                                  

2024 Compensation of Jonathan Dickinson

The following table sets forth the compensation earned by Jonathan Dickinson during the year ended on December 31, 2024:

  Type of Compensation      Amount of Compensation      Description                                                                                                                                   
  Fixed Compensation        €91,666                     Gross fixed compensation pursuant to Jonathan Dickinson's social mandate ( mandat social).                                                    
  Free Shares 2024          €324,000                    This amount was calculated in accordance with the IFRS 2 valuation of the grant to Jonathan Dickinson of 200,000 free shares 2024.            
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Annual Variable           0                           N/A for 2024.                                                                                                                                 
  Benefits in Kind          €19,583                     Primarily represents amounts paid for use of a company car and additional retirement benefits (known as “article 83”), among other benefits.